Kaye Mark bought ELV
March 2, 2026 · Form 4 insider transaction
Kaye Mark bought 25,188 shares of Elevance Health, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,188
Price
$0.00
Total value
N/A
InsiderKaye Mark
Role—
CompanyElevance Health, Inc. (ELV)
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after25,188
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.